EDX Medical Group plc (AQSE:EDX) CEO Dr Mike Hudson joins DirectorsTalk Interviews to discuss a strategic expansion of its cancer testing capability.
In this interview with Dr Mike Hudson, CEO of EDX Medical, we delve into the recent strategic expansion of their cancer testing capabilities. Dr Hudson discusses the innovative approach of EDX Medical in developing digital diagnostic products that support personalised treatments for critical diseases like cancer, heart disease, and infectious diseases. The interview covers the foundation and strength of EDX’s leadership team, the importance of comprehensive hereditary cancer testing, and how these advancements are set to impact patients and the healthcare industry. Additionally, Dr Hudson shares the company’s future plans, including product availability, partnerships, and geographic expansion, offering a glimpse into what investors and stakeholders can anticipate from EDX Medical in the coming months.
